Special Issues


Mechanism of Action: Novel Mechanisms in CINV Treatment

Mechanism of Action: Novel Mechanisms in CINV Treatment

Uncategorized

The role of the neurokinin-1 (NK-1) pathway in chemotherapy-induced nausea and vomiting (CINV) is now well established following ap-proval of the US Food and Drug Administration (FDA) of aprepitant (Emend; Merck), the first NK-1 receptor antagonist (RA), for the treatment [ Read More ]